SS-31
Also known as: Elamipretide · Bendavia · MTP-131
A mitochondria-targeted tetrapeptide that stabilizes the inner membrane to halt age-related energy decline. In clinical trials for heart failure and rare mitochondrial diseases.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~4 hours
0.25 mg/kg
Subcutaneous injection or IV
Mechanism of Action
Binds cardiolipin in the inner mitochondrial membrane, stabilizing electron transport chain complexes and reducing oxidative stress at the source.
Key Research Areas
Frequently Asked Questions
What is SS-31?▾
How does SS-31 work?▾
What is the recommended dosage for SS-31?▾
What is the half-life of SS-31?▾
Is SS-31 FDA approved?▾
Research Disclaimer
The information provided about SS-31 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.